Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elmar Schnee Insider Profile
4 Followers
Elmar Schnee, Director at Jazz Pharmaceuticals, holds 8.27K shares in Jazz Pharmaceuticals (Ticker: JAZZ). Most recently, Elmar Schnee Sold $1,632 shares of Jazz Pharmaceuticals on Aug 09, 2021 for an estimated value of 251.33K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+1.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Elmar Schnee holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 13, 2018 - Aug 13, 2019
Return:+21.90%
The most profitable trade made by Elmar Schnee
Elmar Schnee's Trading History
List of latest transactions for each holding click on a transaction to see Elmar Schnee's performance on stock
You May Also Like
Elmar Schnee insider profile FAQ
What is the percentage of profitable transactions made by Elmar Schnee?
The percentage of profitable transactions made by Elmar Schnee is 50%.
What is the average return per transaction made by Elmar Schnee?
The average return per transaction made by Elmar Schnee is 1.90%.
What stocks does Elmar Schnee hold?
Elmar Schnee holds: JAZZ stocks.
What was Elmar Schnee’s latest transaction?
Elmar Schnee latest transaction was an Informative Sell of $251.33K.
What was Elmar Schnee's most profitable transaction?
Elmar Schnee’s most profitable transaction was an Informative Sell of JAZZ stock on August 13, 2018. The return on the trade was 21.90%.
What is Elmar Schnee's role in Jazz Pharmaceuticals?
Elmar Schnee's role in Jazz Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.